Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young Children
2024
· University of Michigan,
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service
This study evaluated the cost-effectiveness of using nirsevimab to prevent respiratory syncytial virus (RSV) in infants and high-risk children. By analyzing healthcare data, it was …
Ask aRCie
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness
2024
· University of Michigan,
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service
This study evaluates the benefits and cost-effectiveness of a vaccine for pregnant women to protect babies from RSV, a virus that can cause serious illness …
Guidelines for Inpatient Administration of Nirsevimab to Infants and Children
2024
· University of Michigan
This 4-page document explain how to give nirsevimab to infants and children in hospitals. It describes dosing based on age and weight, especially after heart …
Respiratory Syncytial Virus Vaccination Recommendations and Other Updates From ACIP
2023
· University of Michigan
This 2-page practice guideline highlights the impact of respiratory syncytial virus (RSV) infection in the United States, causing severe respiratory illness, especially in infants and …